# Safely Reduce Cystoscopic Evaluations for Hematuria Patients

> **NCT06026189** · NA · RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 1100 (estimated)

## Conditions studied

- Hematuria
- Urothelial Neoplasm
- Urothelial Carcinoma
- Bladder Cancer

## Interventions

- **DIAGNOSTIC_TEST:** urine-first strategy

## Key facts

- **NCT ID:** NCT06026189
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-31
- **Primary completion:** 2026-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06026189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06026189, "Safely Reduce Cystoscopic Evaluations for Hematuria Patients". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT06026189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*